Q3 Revenue Climbs 18% to $5.6M as Nephros Stays Profitable
NEPH sits 16% above its 52-week low of $2.663.
Summary
Nephros posted Q3 2026 net revenue of $5.6 million, up 18% from $4.8 million a year earlier, with net income of $0.5 million versus $0.3 million and Adjusted EBITDA of $0.6 million versus $0.4 million. The quarter follows the record $6.0 million reported in Q2, so sequential revenue slipped even as the year-over-year trend held. Gross margin compressed to 58% from 61%, which management attributed to higher shipping and handling costs including tariffs and a larger mix of lower-margin service revenue. Customer expansion continued: 31 new sites brought the active installed base to a record 1,766, with healthcare about 64% of additions. Nine-month revenue rose 20% to $16.9 million and net income reached $1.8 million; the company holds $4.5 million in cash and no debt. The margin decline and the Q2-to-Q3 sequential dip are the items to weigh against the growth headline.
At the time of this announcement, NEPH was trading at $3.09 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $33.6M. The 52-week trading range was $2.66 to $6.42. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.